Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 118 of 118

TitleReference numberPublishedLast updated
24/7 EEG SubQ for epilepsyMIB277
3C Patch for treating diabetic foot ulcersHTG615
Acute heart failure: diagnosis and managementCG187
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomasMIB294
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adultsES40
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infectionsES39
Atidarsagene autotemcel for treating metachromatic leukodystrophyHST18
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyTA788
Belimumab for treating active autoantibody-positive systemic lupus erythematosusTA752
Bladder EpiCheck for detecting bladder cancer recurrenceMIB293
Brain tumours (primary) and brain metastases in over 16sQS203
Cabotegravir with rilpivirine for treating HIV-1TA757
CerebAir for continuous EEG monitoring in intensive careMIB279
Chronic kidney disease: assessment and managementNG203
ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infectionsHTG602
clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemiaMIB278
Colorectal cancerNG151
Colorectal cancerQS20
Coronary sinus narrowing device implantation for refractory anginaHTG600
d-Nav insulin management app for type 2 diabetesMIB285
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitableTA763
Daratumumab monotherapy for treating relapsed and refractory multiple myelomaTA783
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)TA771
Diabetes in children and young peopleQS125
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiencyTA779
Dupilumab for treating severe asthma with type 2 inflammationTA751
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodulesHTG611
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Empagliflozin for treating chronic heart failure with reduced ejection fractionTA773
Endo-SPONGE for treating low rectal anastomotic leakHTG605
Endoanchoring systems in endovascular aortic aneurysm repairHTG625
Endobronchial nerve ablation for chronic obstructive pulmonary diseaseHTG604
Endoscopic balloon dilation for subglottic or tracheal stenosisHTG614
Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomachHTG612
Fetal alcohol spectrum disorderQS204
Fever in under 5s: assessment and initial managementNG143
Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment)HTG619
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndromeMIB281
Fremanezumab for preventing migraineTA764
Givosiran for treating acute hepatic porphyriaHST16
Glaucoma: diagnosis and managementNG81
Granulox for managing chronic non-healing woundsMIB296
Heart valve disease presenting in adults: investigation and managementNG208
icobrain ms for active relapsing–remitting multiple sclerosisMIB291
Inducing labourNG207
Inducing labourQS60
Integrated health and social care for people experiencing homelessnessNG214
Intramedullary distraction for lower limb lengtheningHTG613
Intramedullary distraction for upper limb lengtheningHTG621
Joint replacement (primary): hip, knee and shoulderQS206
Lenalidomide for relapsed or refractory mantle cell lymphoma (terminated appraisal)TA774
Liposuction for chronic lipoedemaHTG618
Liposuction for chronic lymphoedemaHTG622
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal)TA749
Lumella point-of-care test for assessing pre-eclampsia riskMIB287
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adultsNG215
Mental wellbeing at workNG212
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disordersTA748
Microwave ablation for primary or metastatic cancer in the lungHTG609
Mogamulizumab for previously treated mycosis fungoides and Sézary syndromeTA754
NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal)TA745
Neonatal parenteral nutritionQS205
Nintedanib for treating progressive fibrosing interstitial lung diseasesTA747
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancerTA784
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancerTA746
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785
Nivolumab with ipilimumab for untreated advanced renal cell carcinomaTA780
Odevixibat for treating progressive familial intrahepatic cholestasisHST17
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)TA750
Otitis media (acute): antimicrobial prescribingNG91
Paige Prostate for prostate cancerMIB280
Palforzia for treating peanut allergy in children and young peopleTA769
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuriaTA778
Pelvic floor dysfunction: prevention and non-surgical managementNG210
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanomaTA766
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapiesTA772
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancerTA770
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failureHTG599
Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitisHTG617
Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndromeHTG623
Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA776
Ponesimod for treating relapsing–remitting multiple sclerosisTA767
PredictSURE IBD and IBDX to guide treatment of Crohn's diseaseHTG610
Prontosan for treating acute and chronic woundsHTG616
Prostate cancerQS91
Prostate cancer: diagnosis and managementNG131
Rehabilitation after traumatic injuryNG211
Romosozumab for treating severe osteoporosisTA791
SecurePort IV tissue adhesive for use with percutaneous cathetersMIB288
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive careHTG607
SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoeaHTG598
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and overHST20
Sleepio to treat insomnia and insomnia symptomsHTG624
Smart Peak Flow for monitoring asthmaMIB282
Social work with adults experiencing complex needsNG216
Sodium zirconium cyclosilicate for treating hyperkalaemiaTA599
Solriamfetol for treating excessive daytime sleepiness caused by narcolepsyTA758
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA777
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancerTA781
Stereotactic radiosurgery for trigeminal neuralgiaHTG608
Stroke and transient ischaemic attack in over 16s: diagnosis and initial managementNG128
Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritisHTG626
Synergo for non-muscle-invasive bladder cancerHTG601
Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm (terminated appraisal)TA782
Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterationsTA789
The Insides System for managing intestinal failureMIB286
Transanal total mesorectal excision for rectal cancerHTG603
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal)TA790
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDsTA768
Upadacitinib for treating moderate rheumatoid arthritisTA744
Urinary incontinence in womenQS77
UroShield for preventing catheter-associated urinary tract infectionsHTG620
Vaccine uptake in the general populationNG218
Vaccine uptake in under 19sQS145
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA765
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA787
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsMIB295

Results per page

  1. 10
  2. 25
  3. 50
  4. All